Genomic profiles and their associations with TMB, PD-L1 expression, and immune cell infiltration landscapes in synchronous multiple primary lung cancersChunhong Hu, Fang Wu, Junqi Liu et al.|Journal for ImmunoTherapy of Cancer|2021Cited by 77
The key to immunotherapy: how to choose better therapeutic biomarkers for patients with non-small cell lung cancerYue Pan, Fang Wu, Yucheng Fu et al.|Biomarker Research|2022Cited by 57
Combination of CD47 Expression and SIRI as a Prognostic Factor in Nasopharyngeal Carcinoma PatientsChao Deng, Tao Hou|Research Square|2021Cited by 0